Welcome to our dedicated page for Bark news (Ticker: BARK), a resource for investors and traders seeking the latest updates and insights on Bark stock.
BARK, Inc. (BARK) is frequently in the news as a global omnichannel dog brand focused on products, food, services, and content for dogs. Company press releases emphasize its mission to make all dogs happy and highlight developments across its direct-to-consumer subscriptions, retail partnerships, and newer categories such as premium dog food and dog-first air travel.
News coverage of BARK often centers on financial results and corporate actions. The company issues quarterly earnings updates, such as its fiscal second quarter results, where it reports revenue by segment, gross profit, and key performance indicators like Total Orders and Average Order Value. BARK also files current reports on events affecting its securities, including NYSE notices regarding listing standards and actions related to its publicly traded warrants.
Another major theme in BARK’s news flow is brand and product innovation. Recent announcements include the launch of BARK in the Belly, a premium dog food and consumables line that pledges 100% of food profits to fight canine hunger, and BARK Subscriber Perks, a membership benefit that provides offers and discounts from partners across travel, wellness, dog care, food, and lifestyle. The company also publicizes experiential campaigns such as the BARK Live “Farmer’s Barket” pop-up in New York City and creative advertising like the “Merry Chaos” holiday commercial described as directed by a dog.
Corporate governance and strategic developments also appear in the news. BARK has announced leadership changes, including the promotion of a President, Core Business, and it has disclosed a preliminary non-binding proposal from a stockholder group to acquire all outstanding shares not already owned by that group. Investor letters distributed via newswire further discuss the company’s balance sheet, valuation, and potential strategic directions.
Investors and dog lovers following BARK’s news can expect updates on earnings, segment performance, new product launches, experiential marketing campaigns, retail and technology partnerships, and any significant proposals or listing-related developments. Stock Titan’s BARK news page aggregates these items to provide a centralized view of the company’s ongoing disclosures and public announcements.
BARK (NYSE: BARK), a global omnichannel dog brand, announced preliminary financial results for Q3 FY2025 ended December 31, 2024. Total revenue was approximately $126.4 million, exceeding guidance and marking a 1.1% year-over-year increase. The net loss was approximately $(11.5) million, $1.4 million greater than the same period last year due to a $1.8 million debt extinguishment gain in the prior year. Adjusted EBITDA was approximately $(1.6) million, within guidance and a $4.9 million improvement year-over-year.
CEO Matt Meeker highlighted the company's tenth consecutive quarter of year-over-year Adjusted EBITDA growth and exceeding revenue guidance. Notable achievements include migrating paid media to the BARK.co platform, resulting in 8% growth in new subscribers, and generating $2 million in revenue from BARK Air. The commerce segment also saw over 25% year-to-date growth.
BARK reaffirmed its FY2025 guidance: total revenue of $490 million to $500 million (0-2% growth) and Adjusted EBITDA of $1.0 million to $5.0 million, a $11.6 million to $15.6 million improvement. Full financial results will be announced on February 5, 2025, followed by a live conference call.
BARK (NYSE: BARK) has announced its participation in the 2025 ICR Conference in Orlando, Florida. Co-Founder and CEO Matt Meeker and CFO Zahir Ibrahim will engage in a fireside chat on January 13, 2025, at 4:00 p.m. Eastern Time. The company plans to release its preliminary third-quarter fiscal year 2025 results before the market opens on the same day.
The fireside chat will be accessible via audio webcast on investors.bark.co, with the recording remaining available online for 90 days following the presentation.
BARK (NYSE: BARK) has announced an expansion of BARK Air, the first air travel experience designed for dogs and their owners, through direct air carrier Air Wisconsin. This expansion includes trial flights on larger CRJ-200 aircraft, doubling capacity and offering fares under $1,000. Flights will run between New York City and Miami/Fort Lauderdale starting in February 2025, and bookings are currently open. The expanded service aims to make dog-friendly travel more affordable while maintaining BARK's signature 'white paw' service. The route was chosen based on demand for winter getaways to Florida. BARK’s CEO, Matt Meeker, highlighted that this collaboration with Air Wisconsin will allow the company to serve more passengers at lower prices. Air Wisconsin will manage all aircraft operations, ensuring safety and seamless travel. BARK Air, launched in May 2024, has already offered premium flights to destinations like Los Angeles, New York, London, and Paris. For more details and bookings, visit air.bark.co.
BARK (NYSE: BARK) has announced the first-ever retail launch of its BarkBox subscription product at Target. The Rudolph the Red-Nosed Reindeer-themed box, available in three sizes for different dog sizes, features plush toy versions of holiday characters and treats. The product is available on target.com and will be in Target stores nationwide from December 1. To mark the launch, BARK is partnering with shelters across the country to spotlight adoptable 'misfit' dogs with special circumstances, providing toys, treats, food, beds, and Rudolph-themed BarkBoxes to adopted families.
BARK (NYSE: BARK) announced its financial results for the fiscal second quarter ended September 30, 2024.
Total revenue was $126.1 million, a 2.5% increase year-over-year, exceeding the high-end of the Company's guidance range. Net loss improved by 49.1% to $(5.3) million year-over-year. Adjusted EBITDA was $3.5 million, a $2.5 million improvement year-over-year, also exceeding the guidance range.
Key Performance Indicators:
- Total orders: 3,270 thousand
- Average order value: $30.91
- Gross profit: $76.1 million
- Gross margin: 60.4%
Advertising and marketing expenses increased to $18.7 million, while G&A expenses decreased to $63.1 million. Net cash provided by operating activities was $2.8 million, and free cash flow was $1.0 million.
Balance Sheet Highlights: Cash and cash equivalents were $115.2 million, and inventory was $88.4 million as of September 30, 2024.
Fiscal Third Quarter and Full Year 2025 Financial Outlook: The company reaffirmed its FY 2025 guidance with total revenue of $490 million to $500 million and Adjusted EBITDA of $1.0 million to $5.0 million.
BARK (NYSE: BARK) has partnered with Crocs (NASDAQ: CROX) to launch Pet Crocs, a -edition line of dog shoes matching human Crocs styles. The collection features glow-in-the-dark marbled Green Slime and Pink Dragon Fruit designs, made from breathable EVA foam with adjustable straps and grippy treads. Available in three sizes for dogs weighing 15-80 lbs, Pet Crocs can be obtained through BarkBox and Super Chewer subscriptions or purchased directly from Crocs.com and select retail stores.
BARK, Inc. (NYSE: BARK), a leading global omnichannel brand focused on making dogs happy, has announced that it will release its second quarter fiscal year 2025 financial results after market close on Thursday, November 7, 2024. The company will host a live conference call and webcast at 4:30 p.m. ET on the same day to discuss the results.
Interested parties can access the conference call by dialing 1-888-596-4144 (U.S. participants) or 1-646-968-2525 (international participants) using the passcode 5515653. A live audio webcast will also be available at https://investors.bark.co/ and will be archived for one year.
Crocs (NASDAQ: CROX) is celebrating Croctober with fan-inspired creations. The brand is launching Pet Crocs, designed in partnership with BARK, alongside matching Classic Lined Clogs for humans. These will be available globally on Croc Day, October 23, in two glow-in-the-dark colorways: Green Slime and Pink Dragon Fruit.
Additionally, Crocs is releasing a life-sized Crocs Costume resembling the iconic Classic Clog, complete with Jibbitz™ charms and available in left and right versions. This costume allows fans to become a living Crocs shoe, with arm openings in place of ventilation holes.
Anne Mehlman, Brand President of Crocs, emphasized the brand's commitment to celebrating fan creativity. Crocs is encouraging fans to share their Croctober experiences on social media using the hashtag #Croctober.
BARK (NYSE: BARK) has relaunched its popular Season's Sweetings Advent Calendar for dogs, now available exclusively at Costco stores and on costco.com. The extra-large calendar features 8 holiday-themed BARK toys and 16 treats, designed to help dogs and their owners count down to Christmas together.
Following last year's success, which saw constant restocks and sell-outs, BARK has expanded the calendar's availability to more Costco stores nationwide. The calendar offers 24 surprises, including Christmas-themed dog treats and original BARK toys. Additionally, dog owners can access a digital experience that places their pets in festive holiday filters by scanning a QR code on the calendar.
BARK and Dunkin' are celebrating their 5-year partnership with a new collection of pumpkin spice-themed dog toys. The collaboration, which has raised over $10 million for the Dunkin' Joy in Childhood Foundation since 2020, introduces four new toys inspired by Dunkin's fall flavors:
1. Dunkin'™ Signature Latte Toy ($15 donation)
2. Dunkin'™ Snackin' Bacon Dog Toy ($13 donation)
3. Dunkin'™ Pumpkin Donut Dog Toy ($15 donation)
4. Dunkin'™ Mocha Latte Dog Toy ($15 donation, online only)
The toys are available at select Dunkin' locations and on bark.co/dunkin. Donations support the foundation's programs, including Dogs for Joy®, which brings facility dogs to children's hospitals. To date, the foundation has funded 49 facility dogs across 33 hospitals, impacting hundreds of thousands of young patients.